intraperiton monoclon antibodi ovarian cancer march march phase II studi patient ovarian cancer dose IP monoclon antibodi tumor cell-surfac antigen myelosuppress escal administ activ mci antibodi periton caviti circul maximum blood activ hour IP inject mean inject activ rang circul radiat bone marrow antibodi blood radiat dose medic intern radiat dose mird formul activ patient blood myelosuppress blood radiat marrow cgi excess myelosuppress modest radiat dose antibodi uptak bone attempt absorpt patient intraven IV infus edta sinclair ltd godalm unit kingdom urinari excret mean inject activ fourteen patient assess tumor laparoscopi tumor regress patient palliat ascit patient 